<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="T2" orientation="portrait" position="float">
 <label>Table 2</label>
 <caption>
  <p>Management of part-solid nodules.</p>
 </caption>
 <table frame="hsides" rules="groups" border="0">
  <thead>
   <tr>
    <td align="left" colspan="3" rowspan="1">PART-SOLID NODULES</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Description</td>
    <td align="center" rowspan="1" colspan="1">Findings</td>
    <td align="center" rowspan="1" colspan="1">Management</td>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left" rowspan="1" colspan="1">1 - Benign appearance or behavior</td>
    <td align="center" rowspan="1" colspan="1">• &lt;8.3 mm total diameter (&lt;300 mm
     <sup>3</sup>)
    </td>
    <td align="center" rowspan="1" colspan="1">→ 1 year round</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"/>
    <td align="center" rowspan="1" colspan="1">• solid part VDT&gt;600d</td>
    <td rowspan="1" colspan="1"/>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"/>
    <td align="center" rowspan="1" colspan="1">• benign histology, PET/CT negative</td>
    <td rowspan="1" colspan="1"/>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">2 - Low risk</td>
    <td align="center" rowspan="1" colspan="1">• ≥8.3 mm total diameter (≥ 300 mm
     <sup>3</sup>) and solid part &lt;100 mm
     <sup>3</sup> (&lt;5.8 mm)
    </td>
    <td align="center" rowspan="1" colspan="1">• 5 month LDCT</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"/>
    <td align="center" rowspan="1" colspan="1">• new ≥5.1 to &lt;8.3 mm total diameter (≥70 to &gt;300 mm
     <sup>3</sup>)
    </td>
    <td rowspan="1" colspan="1"/>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">3 - Intermediate risk</td>
    <td align="center" rowspan="1" colspan="1">• ≥8.3 mm (≥300 mm
     <sup>3</sup>) and
    </td>
    <td align="center" rowspan="1" colspan="1">• 3 month LDCT</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"/>
    <td align="center" rowspan="1" colspan="1">a] solid part ≥100 to &lt;300 mm
     <sup>3</sup> (≥5.8 to &lt;8.3 mm)
    </td>
    <td align="center" rowspan="1" colspan="1">• optional PET/CT if solid part ≥300 mm
     <sup>3</sup>
    </td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"/>
    <td align="center" rowspan="1" colspan="1">b] new or growing solid part &lt;70 mm
     <sup>3</sup> (&lt;5.1 mm)
    </td>
    <td align="center" rowspan="1" colspan="1">(≥ 8.3 mm)</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">4 - High risk</td>
    <td align="center" rowspan="1" colspan="1">• solid part ≥300 mm
     <sup>3</sup> (≥8.3 mm)
    </td>
    <td align="center" rowspan="1" colspan="1">• PET/CT</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"/>
    <td align="center" rowspan="1" colspan="1">• new or growing solid component &gt;70 mm
     <sup>3</sup> (&gt;5.1 mm)
    </td>
    <td align="center" rowspan="1" colspan="1">• Tissue sampling
     <sup>∗</sup>
    </td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"/>
    <td align="center" rowspan="1" colspan="1">• other features suggesting malignancy</td>
    <td align="center" rowspan="1" colspan="1">• Contrast-enhanced CT of thorax</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"/>
    <td rowspan="1" colspan="1"/>
    <td align="center" rowspan="1" colspan="1">• Equivocal appearance of a benign finding:</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"/>
    <td rowspan="1" colspan="1"/>
    <td align="center" rowspan="1" colspan="1">1–2 month LDCT</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
